Rob Hegele is Distinguished University Professor of Medicine and Biochemistry, Western University, a
Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada
Rob Hegele is a staff endocrinologist who cares for > 2500 patients at the lipid clinic at University Hospital, London Ontario. He holds the Wolfe Distinguished Medical Research Chair, the Edith Schulich Vinet Chair in Human Genetics and the Blackburn Chair in Cardiovascular Research at Western University. He was first in North America to use 5 medications that are now routinely prescribed to treat high cholesterol or diabetes. His lab discovered the molecular genetic basis of >20 human diseases. He holds a Foundation grant from CIHR and has received uninterrupted operating support since 1990. He has published 740 papers, which have been cited >29,000 times in the medical literature (Clarivate). The website expertscape.com in 2018 ranked him #1 globally in the area of “hypertriglyceridemia” and #1 for “disorders of lipid metabolism”. He has co-authored many clinical practice guidelines for cholesterol, blood pressure and diabetes. He has trained numerous physicians, medical students and graduate students.
Friday, October 25
4:10 PM – 4:20 PM